{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:51:34Z","timestamp":1781596294447,"version":"3.54.5"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Cerebral noradrenergic activity modulates physiological functions of behaviour, cognition, movement, arousal and sleep. This review aims to provide an accurate summary of the current knowledge on the involvement of the noradrenergic system in Parkinson\u2019s Disease (PD) and its clinical correlations based on neuroimaging studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Studies in PD highlight neuromelanin MRI signal loss in the locus coeruleus (LC), and positron emission tomography shows noradrenergic denervation across subcortical and cortical areas. More severe phenotypes of PD, manifesting with cognitive decline, apathy, REM sleep behaviour disorder and autonomic dysfunction, are associated with more severe noradrenergic dysfunction. Conversely more preserved noradrenergic transmission is common in tremulous PD. Furthermore, noradrenergic dysfunction, is also involved in transient motor manifestations such as tremor and freezing of gait.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Recent neuroimaging advances greatly expanded the knowledge about noradrenergic dysfunction pathophysiology in PD. However, pharmacological treatment of its several associated manifestations is still lacking and needs further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11910-026-01499-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:52:32Z","timestamp":1781592752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Noradrenergic Brain in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-2995","authenticated-orcid":false,"given":"Jacopo","family":"Pasquini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9193-3150","authenticated-orcid":false,"given":"Giovanni","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-6194","authenticated-orcid":false,"given":"Nicola","family":"Pavese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-9406","authenticated-orcid":false,"given":"Roberto","family":"Ceravolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"11","key":"1499_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41583-020-0360-9","volume":"21","author":"GR Poe","year":"2020","unstructured":"Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. Locus coeruleus: a new look at the blue spot. Nat Rev Neurosci. 2020;21(11):644\u201359. https:\/\/doi.org\/10.1038\/s41583-020-0360-9.","journal-title":"Nat Rev Neurosci"},{"key":"1499_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0079-6123(08)63835-2","volume":"88","author":"SJ Sara","year":"1991","unstructured":"Sara SJ, Segal M. Plasticity of sensory responses of Locus coeruleus neurons in the behaving rat: implications for cognition. Prog Brain Res. 1991;88:571\u201385. https:\/\/doi.org\/10.1016\/S0079-6123(08)63835-2.","journal-title":"Prog Brain Res"},{"key":"1499_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0361-9230(94)90159-7","volume":"35","author":"SJ Sara","year":"1994","unstructured":"Sara SJ, Vankov A, Herv\u00e9 A. Locus coeruleus-evoked responses in behaving rats: a clue to the role of noradrenaline in memory. Brain Res Bull. 1994;35:457\u201365. https:\/\/doi.org\/10.1016\/0361-9230(94)90159-7.","journal-title":"Brain Res Bull"},{"key":"1499_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPSYCH.2011.01.027","author":"AFT Arnsten","year":"2011","unstructured":"Arnsten AFT. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry. 2011. https:\/\/doi.org\/10.1016\/J.BIOPSYCH.2011.01.027.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1499_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/J.NEURON.2012.09.011","volume":"76","author":"SJ Sara","year":"2012","unstructured":"Sara SJ, Bouret S. Orienting and reorienting: the Locus coeruleus mediates cognition through arousal. Neuron. 2012;76(1):130\u201341. https:\/\/doi.org\/10.1016\/J.NEURON.2012.09.011.","journal-title":"Neuron"},{"key":"1499_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0006-8993(75)90699-X","volume":"86","author":"SL Foote","year":"1975","unstructured":"Foote SL, Freedman R, Oliver AP. Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res. 1975;86:229\u201342. https:\/\/doi.org\/10.1016\/0006-8993(75)90699-X.","journal-title":"Brain Res"},{"key":"1499_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/SCIENCE.1094539","volume":"189","author":"JA Hobson","year":"1975","unstructured":"Hobson JA, Mccarley RW, Wyzinski PW. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science. 1975;189:55\u20138. https:\/\/doi.org\/10.1126\/SCIENCE.1094539.","journal-title":"Science"},{"issue":"Suppl 2","key":"1499_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003495-198400282-00002","volume":"28","author":"PB Molinoff","year":"1984","unstructured":"Molinoff PB. Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs. 1984;28(Suppl 2):1\u201315. https:\/\/doi.org\/10.2165\/00003495-198400282-00002.","journal-title":"Drugs"},{"key":"1499_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1568007043337535","volume":"3","author":"L Hertz","year":"2004","unstructured":"Hertz L, Chen Y, Gibbs ME, Zang P, Peng L. Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders? Curr Drug Targets CNS Neurol Disord. 2004;3:239\u201367. https:\/\/doi.org\/10.2174\/1568007043337535.","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"1499_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/ANNUREV.NEURO.28.061604.135709","volume":"28","author":"G Aston-Jones","year":"2005","unstructured":"Aston-Jones G, Cohen JD. An integrative theory of Locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci. 2005;28:403\u201350. https:\/\/doi.org\/10.1146\/ANNUREV.NEURO.28.061604.135709.","journal-title":"Annu Rev Neurosci"},{"key":"1499_CR11","doi-asserted-by":"publisher","first-page":"R1051","DOI":"10.1016\/J.CUB.2015.09.039\/ASSET\/564F3577-AA29-4942-9A50-BFA1F2AA01CF\/MAIN.ASSETS\/GR2.JPG","volume":"25","author":"LA Schwarz","year":"2015","unstructured":"Schwarz LA, Luo L. Organization of the Locus Coeruleus-norepinephrine system. Curr Biol. 2015;25:R1051-6. https:\/\/doi.org\/10.1016\/J.CUB.2015.09.039\/ASSET\/564F3577-AA29-4942-9A50-BFA1F2AA01CF\/MAIN.ASSETS\/GR2.JPG.","journal-title":"Curr Biol"},{"key":"1499_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/jnnp.16.4.213","volume":"16","author":"JG Greenfield","year":"1953","unstructured":"Greenfield JG, Bosanquet FD. The brain-stem lesions in parkinsonism. J Neurol Neurosurg Psychiatry. 1953;16:213\u201326. https:\/\/doi.org\/10.1136\/jnnp.16.4.213.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1499_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF01813986","volume":"111","author":"R Klaue","year":"1940","unstructured":"Klaue R. Parkinsonsche Krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus - Versuch einer klinisch-anatomischen Differentialdiagnose. Arch Psychiatr Nervenkr. 1940;111:251\u2013321. https:\/\/doi.org\/10.1007\/BF01813986.","journal-title":"Arch Psychiatr Nervenkr"},{"key":"1499_CR14","unstructured":"Hassler R. Zur Pathologic der Paralysis Agitans und des Post-Enzephalitischen Parkinsonismus. J Psychol Neurol,,. J Psychol Neurol. 1938;18."},{"key":"1499_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","volume":"24","author":"PE Duffy","year":"1965","unstructured":"Duffy PE, Tennyson VM. Phase and electron microscopic observations of Lewy bodies and melanin granules in the Substantia Nigra and Locus Caeruleus in Parkinson\u2019s disease. J Neuropathol Exp Neurol. 1965;24:398\u2013414. https:\/\/doi.org\/10.1097\/00005072-196507000-00003.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1499_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00688674","volume":"34","author":"LS Forno","year":"1976","unstructured":"Forno LS, Norville RL. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol. 1976;34:183\u201397. https:\/\/doi.org\/10.1007\/BF00688674.","journal-title":"Acta Neuropathol"},{"key":"1499_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.410320510","volume":"32","author":"DC German","year":"1992","unstructured":"German DC, Manaye KF, White CL, Woodward DJ, McIntire DD, Smith WK, et al. Disease-specific patterns of Locus Coeruleus cell loss. Ann Neurol. 1992;32:667\u201376. https:\/\/doi.org\/10.1002\/ana.410320510.","journal-title":"Ann Neurol"},{"key":"1499_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Steur ENHJ, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"key":"1499_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s004010051150","volume":"99","author":"H Braak","year":"2000","unstructured":"Braak H, R\u00fcb U, Sandmann-Keil D, Gai WP, de Vos RAI, Steur ENHJ, et al. Parkinson\u2019s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol. 2000;99:489\u201395. https:\/\/doi.org\/10.1007\/s004010051150.","journal-title":"Acta Neuropathol"},{"key":"1499_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","volume":"42","author":"CW Berridge","year":"2003","unstructured":"Berridge CW, Waterhouse BD. The Locus coeruleus\u2013noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev. 2003;42:33\u201384. https:\/\/doi.org\/10.1016\/S0165-0173(03)00143-7.","journal-title":"Brain Res Rev"},{"key":"1499_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/BF02147990","volume":"20","author":"A Dahlstr\u00f6m","year":"1964","unstructured":"Dahlstr\u00f6m A, Fuxe K. Localization of monoamines in the lower brain stem. Experientia. 1964;20:398\u20139. https:\/\/doi.org\/10.1007\/BF02147990.","journal-title":"Experientia"},{"issue":"5","key":"1499_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrn1902","volume":"7","author":"PG Guyenet","year":"2006","unstructured":"Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7(5):335\u201346. https:\/\/doi.org\/10.1038\/nrn1902.","journal-title":"Nat Rev Neurosci"},{"key":"1499_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/CNE.902610405","volume":"261","author":"W Kutsch","year":"1987","unstructured":"Kutsch W, Schneider H. Histological characterization of neurones innervating functionally different muscles of Locusta. J Comp Neurol. 1987;261:515\u201328. https:\/\/doi.org\/10.1002\/CNE.902610405.","journal-title":"J Comp Neurol"},{"key":"1499_CR24","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.1073\/PNAS.1320827111","volume":"111","author":"DJ Chandler","year":"2014","unstructured":"Chandler DJ, Gao WJ, Waterhouse BD. Heterogeneous organization of the Locus Coeruleus projections to prefrontal and motor cortices. Proc Natl Acad Sci U S A. 2014;111:6816\u201321. https:\/\/doi.org\/10.1073\/PNAS.1320827111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1499_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/NRN2573","volume":"10","author":"SJ Sara","year":"2009","unstructured":"Sara SJ. The Locus Coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci. 2009;10:211\u201323. https:\/\/doi.org\/10.1038\/NRN2573.","journal-title":"Nat Rev Neurosci"},{"key":"1499_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/J.NEURON.2019.05.034","volume":"103","author":"V Zerbi","year":"2019","unstructured":"Zerbi V, Floriou-Servou A, Markicevic M, Vermeiren Y, Sturman O, Privitera M, et al. Rapid reconfiguration of the functional connectome after chemogenetic Locus Coeruleus activation. Neuron. 2019;103:702-718.e5. https:\/\/doi.org\/10.1016\/J.NEURON.2019.05.034.","journal-title":"Neuron"},{"key":"1499_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/CNE.901870405","volume":"187","author":"ST Mason","year":"1979","unstructured":"Mason ST, Fibiger HC. Regional topography within noradrenergic Locus Coeruleus as revealed by retrograde transport of horseradish peroxidase. J Comp Neurol. 1979;187:703\u201324. https:\/\/doi.org\/10.1002\/CNE.901870405.","journal-title":"J Comp Neurol"},{"issue":"7563","key":"1499_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature14600","volume":"524","author":"LA Schwarz","year":"2015","unstructured":"Schwarz LA, Miyamichi K, Gao XJ, Beier KT, Weissbourd B, Deloach KE, et al. Viral-genetic tracing of the input\u2013output organization of a central noradrenaline circuit. Nature. 2015;524(7563):88\u201392. https:\/\/doi.org\/10.1038\/nature14600.","journal-title":"Nature"},{"key":"1499_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.92.13.6032","volume":"92","author":"SJ Sara","year":"1995","unstructured":"Sara SJ, Herv\u00e9-Minvielle A. Inhibitory influence of frontal cortex on Locus Coeruleus neurons. Proc Natl Acad Sci U S A. 1995;92:6032. https:\/\/doi.org\/10.1073\/PNAS.92.13.6032.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1499_CR30","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/SCIENCE.3775363","volume":"234","author":"G Aston-Jones","year":"1986","unstructured":"Aston-Jones G, Ennis M, Pieribone VA, Nickell WT, Shipley MT. The brain nucleus Locus Coeruleus: restricted afferent control of a broad efferent network. Science. 1986;234:734\u20137. https:\/\/doi.org\/10.1126\/SCIENCE.3775363.","journal-title":"Science"},{"key":"1499_CR31","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/MRM.26584","volume":"78","author":"P Trujillo","year":"2017","unstructured":"Trujillo P, Summers PE, Ferrari E, Zucca FA, Sturini M, Mainardi LT, et al. Contrast mechanisms associated with neuromelanin-MRI. Magn Reson Med. 2017;78:1790\u2013800. https:\/\/doi.org\/10.1002\/MRM.26584.","journal-title":"Magn Reson Med"},{"key":"1499_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroimage.2019.06.049","volume":"200","author":"P Trujillo","year":"2019","unstructured":"Trujillo P, Petersen KJ, Cronin MJ, Lin YC, Kang H, Donahue MJ, et al. Quantitative magnetization transfer imaging of the human Locus Coeruleus. Neuroimage. 2019;200:191\u20138. https:\/\/doi.org\/10.1016\/j.neuroimage.2019.06.049.","journal-title":"Neuroimage"},{"key":"1499_CR33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","volume":"17","author":"M Sasaki","year":"2006","unstructured":"Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, et al. Neuromelanin magnetic resonance imaging of Locus Ceruleus and Substantia Nigra in Parkinson\u2019s disease. Neuroreport. 2006;17:1215\u20138. https:\/\/doi.org\/10.1097\/01.wnr.0000227984.84927.a7.","journal-title":"Neuroreport"},{"key":"1499_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/J.NEUROIMAGE.2015.03.020","volume":"113","author":"NI Keren","year":"2015","unstructured":"Keren NI, Taheri S, Vazey EM, Morgan PS, Granholm ACE, Aston-Jones GS, et al. Histologic validation of Locus Coeruleus MRI contrast in post-mortem tissue. Neuroimage. 2015;113:235\u201345. https:\/\/doi.org\/10.1016\/J.NEUROIMAGE.2015.03.020.","journal-title":"Neuroimage"},{"key":"1499_CR35","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.1807983116","volume":"116","author":"CM Cassidy","year":"2019","unstructured":"Cassidy CM, Zucca FA, Girgis RR, Baker SC, Weinstein JJ, Sharp ME, et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci U S A. 2019;116:5108\u201317. https:\/\/doi.org\/10.1073\/pnas.1807983116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1499_CR36","doi-asserted-by":"publisher","unstructured":"Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, et al. The role of iron and molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A [Internet]. National Academy of Sciences; 2004 [cited 2025 Aug 6];101:9843\u20138. https:\/\/doi.org\/10.1073\/PNAS.0403495101\/ASSET\/B23CA340-A610-4D2E-92D7-D710042E41A6\/ASSETS\/GRAPHIC\/ZPQ0260452660007.JPEG","DOI":"10.1073\/PNAS.0403495101\/ASSET\/B23CA340-A610-4D2E-92D7-D710042E41A6\/ASSETS\/GRAPHIC\/ZPQ0260452660007.JPEG"},{"key":"1499_CR37","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1093\/BRAIN\/AWZ193","volume":"142","author":"MJ Betts","year":"2019","unstructured":"Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, et al. Locus Coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain. 2019;142:2558\u201371. https:\/\/doi.org\/10.1093\/BRAIN\/AWZ193.","journal-title":"Brain"},{"key":"1499_CR38","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1093\/brain\/awab236","volume":"144","author":"CEJ Doppler","year":"2021","unstructured":"Doppler CEJ, Kinnerup MB, Brune C, Farrher E, Betts M, Fedorova TD, et al. Regional Locus Coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson\u2019s disease. Brain. 2021;144:2732\u201344. https:\/\/doi.org\/10.1093\/brain\/awab236.","journal-title":"Brain"},{"key":"1499_CR39","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/BRAIN\/AWX348","volume":"141","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer M, Fedorova TD, Hansen AK, Knudsen K, Otto M, Jeppesen J, et al. Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study. Brain. 2018;141:496\u2013504. https:\/\/doi.org\/10.1093\/BRAIN\/AWX348.","journal-title":"Brain"},{"key":"1499_CR40","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/HBM.24935","volume":"41","author":"T Liebe","year":"2020","unstructured":"Liebe T, Kaufmann J, Li M, Skalej M, Wagner G, Walter M. In vivo anatomical mapping of human Locus Coeruleus functional connectivity at 3 T MRI. Hum Brain Mapp. 2020;41:2136\u201351. https:\/\/doi.org\/10.1002\/HBM.24935.","journal-title":"Hum Brain Mapp"},{"key":"1499_CR41","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1002\/HBM.22466","volume":"35","author":"PR Murphy","year":"2014","unstructured":"Murphy PR, O\u2019Connell RG, O\u2019Sullivan M, Robertson IH, Balsters JH. Pupil diameter covaries with BOLD activity in human Locus Coeruleus. Hum Brain Mapp. 2014;35:4140\u201354. https:\/\/doi.org\/10.1002\/HBM.22466.","journal-title":"Hum Brain Mapp"},{"issue":"6","key":"1499_CR42","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1212\/WNL.53.6.1212","volume":"53","author":"WD Brown","year":"1999","unstructured":"Brown WD, Taylor MD, Roberts AD, Oakes TR, Schueller MJ, Holden JE, et al. FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa. Neurology. 1999;53(6):1212\u20131212. https:\/\/doi.org\/10.1212\/WNL.53.6.1212.","journal-title":"Neurology"},{"key":"1499_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0006-8993(03)02721-5","volume":"982","author":"RY Moore","year":"2003","unstructured":"Moore RY, Whone AL, McGowan S, Brooks DJ. Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study. Brain Res. 2003;982:137\u201345. https:\/\/doi.org\/10.1016\/S0006-8993(03)02721-5.","journal-title":"Brain Res"},{"key":"1499_CR44","doi-asserted-by":"publisher","unstructured":"Scheffel U, Lever JR, Abraham P, Parham KR, Mathews WB, Kopajtic T, et al. N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter. Synapse [Internet]. Synapse; 1997 [cited 2025 Aug 26];25:345\u20139. https:\/\/doi.org\/10.1002\/(SICI)1098-2396(199704)25:4","DOI":"10.1002\/(SICI)1098-2396(199704)25:4"},{"key":"1499_CR45","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/S00259-007-0621-0\/TABLES\/1","volume":"35","author":"J Booij","year":"2008","unstructured":"Booij J, Kemp P. Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging. 2008;35:424\u201338. https:\/\/doi.org\/10.1007\/S00259-007-0621-0\/TABLES\/1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1499_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2011.00179","volume":"5","author":"IU Isaias","year":"2011","unstructured":"Isaias IU, Marzegan A, Pezzoli G, Marotta G, Canesi M, Biella GEM, et al. A role for Locus Coeruleus in Parkinson tremor. Front Hum Neurosci. 2011;5:179. https:\/\/doi.org\/10.3389\/fnhum.2011.00179.","journal-title":"Front Hum Neurosci"},{"key":"1499_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-88","volume":"11","author":"IU Isaias","year":"2011","unstructured":"Isaias IU, Marotta G, Pezzoli G, Sabri O, Schwarz J, Crenna P, et al. Enhanced catecholamine transporter binding in the Locus Coeruleus of patients with early Parkinson disease. BMC Neurol. 2011;11:88. https:\/\/doi.org\/10.1186\/1471-2377-11-88.","journal-title":"BMC Neurol"},{"key":"1499_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/J.PARKRELDIS.2024.107086","author":"S Kim","year":"2024","unstructured":"Kim S, Woo KA, Choi H, Shin JH, Kim HJ. Monoaminergic degeneration, cognition, and autonomic symptom trajectory in early Parkinson\u2019s disease. Parkinsonism Relat Disord. 2024. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2024.107086.","journal-title":"Parkinsonism Relat Disord"},{"key":"1499_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0197-4580(97)00034-1","volume":"18","author":"TG Ohm","year":"1997","unstructured":"Ohm TG, Busch C, Bohl J. Unbiased estimation of neuronal numbers in the human Nucleus Coeruleus during aging. Neurobiol Aging. 1997;18:393\u20139. https:\/\/doi.org\/10.1016\/S0197-4580(97)00034-1.","journal-title":"Neurobiol Aging"},{"key":"1499_CR50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/BRAIN\/97.1.489","volume":"97","author":"DMA Mann","year":"1974","unstructured":"Mann DMA, Yates PO. Lipoprotein pigments\u2014their relationship to ageing in the human nervous system: II. The melanin content of pigmented nerve cells. Brain. 1974;97:489\u201398. https:\/\/doi.org\/10.1093\/BRAIN\/97.1.489.","journal-title":"Brain"},{"key":"1499_CR51","doi-asserted-by":"crossref","unstructured":"Giorgi FS, Lombardo F, Galgani A, Hlavata H, Della Latta D, Martini N, et al. Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects. Brain Imaging Behav [Internet]. Springer; 2022 [cited 2026 Feb 11];16:1077\u201387. 10.1007\/S11682-021-00562-0\/FIGURES\/2","DOI":"10.1007\/s11682-021-00562-0"},{"key":"1499_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/J.NEUROBIOLAGING.2018.10.014","volume":"74","author":"KY Liu","year":"2019","unstructured":"Liu KY, Acosta-Cabronero J, Cardenas-Blanco A, Loane C, Berry AJ, Betts MJ, et al. In vivo visualization of age-related differences in the locus coeruleus. Neurobiol Aging. 2019;74:101\u201311. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2018.10.014.","journal-title":"Neurobiol Aging"},{"key":"1499_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2463\/MRMS.5.197","volume":"5","author":"E Shibata","year":"2006","unstructured":"Shibata E, Sasaki M, Tohyama K, Kanbara Y, Otsuka K, Ehara S, et al. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci. 2006;5:197\u2013200. https:\/\/doi.org\/10.2463\/MRMS.5.197.","journal-title":"Magn Reson Med Sci"},{"key":"1499_CR54","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/J.NEUROIMAGE.2017.09.042","volume":"163","author":"MJ Betts","year":"2017","unstructured":"Betts MJ, Cardenas-Blanco A, Kanowski M, Jessen F, D\u00fczel E. In vivo MRI assessment of the human locus coeruleus along its rostrocaudal extent in young and older adults. Neuroimage. 2017;163:150\u20139. https:\/\/doi.org\/10.1016\/J.NEUROIMAGE.2017.09.042.","journal-title":"Neuroimage"},{"key":"1499_CR55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/J.NEUROBIOLAGING.2025.03.005","volume":"150","author":"E Riley","year":"2025","unstructured":"Riley E, Cicero N, Mabry SA, Swallow KM, Anderson AK, De Rosa E. Age-related differences in locus coeruleus intensity across a demographically diverse sample. Neurobiol Aging. 2025;150:122\u201331. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2025.03.005.","journal-title":"Neurobiol Aging"},{"key":"1499_CR56","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41562-019-0715-2","volume":"3","author":"MJ Dahl","year":"2019","unstructured":"Dahl MJ, Mather M, D\u00fczel S, Bodammer NC, Lindenberger U, K\u00fchn S, et al. Rostral locus coeruleus integrity is associated with better memory performance in older adults. Nat Hum Behav. 2019;3:1203\u201314. https:\/\/doi.org\/10.1038\/s41562-019-0715-2.","journal-title":"Nat Hum Behav"},{"issue":"1","key":"1499_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15410-w","volume":"11","author":"KY Liu","year":"2020","unstructured":"Liu KY, Kievit RA, Tsvetanov KA, Betts MJ, D\u00fczel E, Rowe JB, et al. Noradrenergic-dependent functions are associated with age-related locus coeruleus signal intensity differences. Nat Commun. 2020;11(1):1\u20139. https:\/\/doi.org\/10.1038\/s41467-020-15410-w.","journal-title":"Nat Commun"},{"issue":"9","key":"1499_CR58","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s43587-023-00469-z","volume":"3","author":"MJ Dahl","year":"2023","unstructured":"Dahl MJ, Bachman SL, Dutt S, D\u00fczel S, Bodammer NC, Lindenberger U, et al. The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance. Nat Aging. 2023;3(9):1128\u201343. https:\/\/doi.org\/10.1038\/s43587-023-00469-z.","journal-title":"Nat Aging"},{"key":"1499_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/SYN.20696","volume":"64","author":"YS Ding","year":"2010","unstructured":"Ding YS, Singhal T, Planeta-Wilson B, Gallezot JD, Nabulsi N, Labaree D, et al. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[11C]O-Methylreboxetine and HRRT. Synapse. 2010;64:30. https:\/\/doi.org\/10.1002\/SYN.20696.","journal-title":"Synapse"},{"issue":"7","key":"1499_CR60","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2967\/JNUMED.116.178913","volume":"58","author":"S Moriguchi","year":"2017","unstructured":"Moriguchi S, Kimura Y, Ichise M, Arakawa R, Takano H, Seki C, et al. PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2. J Nucl Med. 2017;58(7):1140\u20135. https:\/\/doi.org\/10.2967\/JNUMED.116.178913.","journal-title":"J Nucl Med"},{"key":"1499_CR61","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2967\/JNUMED.114.145565","volume":"56","author":"A Nahimi","year":"2015","unstructured":"Nahimi A, Jakobsen S, Munk OL, Vang K, Phan JA, Rodell A, et al. Mapping \u03b12 adrenoceptors of the human brain with 11C-yohimbine. J Nucl Med. 2015;56:392\u20138. https:\/\/doi.org\/10.2967\/JNUMED.114.145565.","journal-title":"J Nucl Med"},{"key":"1499_CR62","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/CNE.902870308","volume":"287","author":"V Chan\u2010Palay","year":"1989","unstructured":"Chan\u2010Palay V, Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression. J Comp Neurol. 1989;287:373\u201392. https:\/\/doi.org\/10.1002\/CNE.902870308.","journal-title":"J Comp Neurol"},{"key":"1499_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0006-8993(77)90214-1","volume":"126","author":"IJ Farley","year":"1977","unstructured":"Farley IJ, Hornykiewicz O. Noradrenaline distribution in subcortical areas of the human brain. Brain Res. 1977;126:53\u201362. https:\/\/doi.org\/10.1016\/0006-8993(77)90214-1.","journal-title":"Brain Res"},{"key":"1499_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","volume":"639","author":"K Shannak","year":"1994","unstructured":"Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson\u2019s disease and normal subjects. Brain Res. 1994;639:33\u201341. https:\/\/doi.org\/10.1016\/0006-8993(94)91761-2.","journal-title":"Brain Res"},{"key":"1499_CR65","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/ARCHNEUR.1984.04210080020007","volume":"41","author":"SJ Kish","year":"1984","unstructured":"Kish SJ, Shannak KS, Rajput AH, Gilbert JJ, Hornykiewicz O. Cerebellar norepinephrine in patients with Parkinson\u2019s Disease and control subjects. Arch Neurol. 1984;41:612\u20134. https:\/\/doi.org\/10.1001\/ARCHNEUR.1984.04210080020007.","journal-title":"Arch Neurol"},{"key":"1499_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/S40035-024-00400-5","author":"CP Lin","year":"2024","unstructured":"Lin CP, Frigerio I, Bol JGJM, Bouwman MMA, Wesseling AJ, Dahl MJ, et al. Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer\u2019s disease and Parkinson\u2019s disease. Transl Neurodegener. 2024. https:\/\/doi.org\/10.1186\/S40035-024-00400-5.","journal-title":"Transl Neurodegener"},{"key":"1499_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ANA.410300308","volume":"30","author":"P Gaspar","year":"1991","unstructured":"Gaspar P, Duyckaerts C, Alvarez C, Javoy\u2010Agid F, Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson\u2019s disease. Ann Neurol. 1991;30:365\u201374. https:\/\/doi.org\/10.1002\/ANA.410300308.","journal-title":"Ann Neurol"},{"key":"1499_CR68","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/MDS.25109","volume":"27","author":"C Pifl","year":"2012","unstructured":"Pifl C, Kish SJ, Hornykiewicz O. Thalamic noradrenaline in Parkinson\u2019s disease: deficits suggest role in motor and non-motor symptoms. Mov Disord. 2012;27:1618\u201324. https:\/\/doi.org\/10.1002\/MDS.25109.","journal-title":"Mov Disord"},{"key":"1499_CR69","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/BRAIN\/AWT152","volume":"136","author":"D Garc\u00eda-Lorenzo","year":"2013","unstructured":"Garc\u00eda-Lorenzo D, Santos C-D, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, et al. The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson\u2019s disease. Brain. 2013;136:2120\u20139. https:\/\/doi.org\/10.1093\/BRAIN\/AWT152.","journal-title":"Brain"},{"key":"1499_CR70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000350291","volume":"70","author":"K Matsuura","year":"2013","unstructured":"Matsuura K, Maeda M, Yata K, Ichiba Y, Yamaguchi T, Kanamaru K, et al. Neuromelanin magnetic resonance imaging in Parkinson\u2019s disease and multiple system atrophy. Eur Neurol. 2013;70:70\u20137. https:\/\/doi.org\/10.1159\/000350291.","journal-title":"Eur Neurol"},{"key":"1499_CR71","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","volume":"20","author":"C Ohtsuka","year":"2014","unstructured":"Ohtsuka C, Sasaki M, Konno K, Kato K, Takahashi J, Yamashita F, et al. Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord. 2014;20:755\u201360. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.04.005.","journal-title":"Parkinsonism Relat Disord"},{"key":"1499_CR72","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1148\/radiol.2016160662","volume":"283","author":"ST Schwarz","year":"2017","unstructured":"Schwarz ST, Xing Y, Tomar P, Bajaj N, Auer DP. In vivo assessment of brainstem depigmentation in Parkinson Disease: potential as a severity marker for multicenter studies. Radiology. 2017;283:789\u201398. https:\/\/doi.org\/10.1148\/radiol.2016160662.","journal-title":"Radiology"},{"key":"1499_CR73","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/MDS.26201","volume":"30","author":"G Castellanos","year":"2015","unstructured":"Castellanos G, Fern\u00e1ndez-Seara MA, Lorenzo-Betancor O, Ortega-Cubero S, Puigvert M, Uranga J, et al. Automated neuromelanin imaging as a diagnostic biomarker for Parkinson\u2019s disease. Mov Disord. 2015;30:945\u201352. https:\/\/doi.org\/10.1002\/MDS.26201.","journal-title":"Mov Disord"},{"key":"1499_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2016.00196","author":"IU Isaias","year":"2016","unstructured":"Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G, et al. Neuromelanin imaging and dopaminergic loss in Parkinson\u2019s Disease. Front Aging Neurosci. 2016. https:\/\/doi.org\/10.3389\/FNAGI.2016.00196.","journal-title":"Front Aging Neurosci"},{"key":"1499_CR75","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/ENE.13628","volume":"25","author":"J Wang","year":"2018","unstructured":"Wang J, Li Y, Huang Z, Wan W, Zhang Y, Wang C, et al. Neuromelanin-sensitive magnetic resonance imaging features of the Substantia Nigra and Locus Coeruleus in de novo Parkinson\u2019s disease and its phenotypes. Eur J Neurol. 2018;25:949-e73. https:\/\/doi.org\/10.1111\/ENE.13628.","journal-title":"Eur J Neurol"},{"key":"1499_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/J.NEUBIOREV.2017.10.023","volume":"83","author":"KY Liu","year":"2017","unstructured":"Liu KY, Marijatta F, H\u00e4mmerer D, Acosta-Cabronero J, D\u00fczel E, Howard RJ. Magnetic resonance imaging of the human Locus Coeruleus: a systematic review. Neurosci Biobehav Rev. 2017;83:325\u201355. https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2017.10.023.","journal-title":"Neurosci Biobehav Rev"},{"key":"1499_CR77","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/MDS.29309","volume":"38","author":"A Nobileau","year":"2023","unstructured":"Nobileau A, Gaurav R, Chougar L, Faucher A, Valabr\u00e8gue R, Mangone G, et al. Neuromelanin-sensitive magnetic resonance imaging changes in the locus coeruleus\/subcoeruleus complex in patients with typical and atypical parkinsonism. Mov Disord. 2023;38:479\u201384. https:\/\/doi.org\/10.1002\/MDS.29309.","journal-title":"Mov Disord"},{"key":"1499_CR78","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/MDS.28945","volume":"37","author":"CF Madelung","year":"2022","unstructured":"Madelung CF, Meder D, Fuglsang SA, Marques MM, Boer VO, Madsen KH, et al. Locus coeruleus shows a spatial pattern of structural disintegration in Parkinson\u2019s disease. Mov Disord. 2022;37:479\u201389. https:\/\/doi.org\/10.1002\/MDS.28945.","journal-title":"Mov Disord"},{"key":"1499_CR79","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/mds.29072","volume":"37","author":"R Ye","year":"2022","unstructured":"Ye R, O\u2019Callaghan C, Rua C, Hezemans FH, Holland N, Malpetti M, et al. Locus coeruleus integrity from 7 T MRI relates to apathy and cognition in Parkinsonian disorders. Mov Disord. 2022;37:1663\u201372. https:\/\/doi.org\/10.1002\/mds.29072.","journal-title":"Mov Disord"},{"key":"1499_CR80","doi-asserted-by":"publisher","DOI":"10.1093\/BRAINCOMMS\/FCAF023","author":"J Pasquini","year":"2025","unstructured":"Pasquini J, Firbank MJ, Best L, Foster V, Stewart C, Silani V, et al. Substantia nigra and locus coeruleus microstructural abnormalities in isolated rapid eye movement sleep behaviour disorder and Parkinson\u2019s disease. Brain Commun. 2025. https:\/\/doi.org\/10.1093\/BRAINCOMMS\/FCAF023.","journal-title":"Brain Commun"},{"key":"1499_CR81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF00274983","volume":"77","author":"KG Baker","year":"1989","unstructured":"Baker KG, Tork I, Hornung JP, Halasz P. The human locus coeruleus complex: an immunohistochemical and three dimensional reconstruction study. Exp Brain Res. 1989;77:257\u201370. https:\/\/doi.org\/10.1007\/BF00274983.","journal-title":"Exp Brain Res"},{"key":"1499_CR82","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/cne.902870308","volume":"287","author":"V Chan-Palay","year":"1989","unstructured":"Chan-Palay V, Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression. J Comp Neurol. 1989;287:373\u201392. https:\/\/doi.org\/10.1002\/cne.902870308.","journal-title":"J Comp Neurol"},{"key":"1499_CR83","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2967\/jnumed.117.190975","volume":"59","author":"A Nahimi","year":"2018","unstructured":"Nahimi A, Sommerauer M, Kinnerup MB, \u00d8stergaard K, Wintherdahl M, Jacobsen J, et al. Noradrenergic deficits in Parkinson disease imaged with 11C-MeNER. J Nucl Med. 2018;59:659\u201364. https:\/\/doi.org\/10.2967\/jnumed.117.190975.","journal-title":"J Nucl Med"},{"key":"1499_CR84","doi-asserted-by":"publisher","DOI":"10.1093\/SLEEP\/ZSAB040","author":"CEJ Doppler","year":"2021","unstructured":"Doppler CEJ, Smit JAM, Hommelsen M, Seger A, Horsager J, Kinnerup MB, et al. Microsleep disturbances are associated with noradrenergic dysfunction in Parkinson\u2019s disease. Sleep. 2021. https:\/\/doi.org\/10.1093\/SLEEP\/ZSAB040.","journal-title":"Sleep"},{"key":"1499_CR85","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/MDS.27411","volume":"33","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer M, Hansen AK, Parbo P, Fedorova TD, Knudsen K, Frederiksen Y, et al. Decreased noradrenaline transporter density in the motor cortex of Parkinson\u2019s Disease patients. Mov Disord. 2018;33:1006\u201310. https:\/\/doi.org\/10.1002\/MDS.27411.","journal-title":"Mov Disord"},{"key":"1499_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105295","volume":"152","author":"MB Kinnerup","year":"2021","unstructured":"Kinnerup MB, Sommerauer M, Damholdt MF, Schaldemose JL, Ismail R, Terkelsen AJ, et al. Preserved noradrenergic function in Parkinson\u2019s Disease patients with rest tremor. Neurobiol Dis. 2021;152:105295. https:\/\/doi.org\/10.1016\/j.nbd.2021.105295.","journal-title":"Neurobiol Dis"},{"key":"1499_CR87","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/BRAIN\/AWAD338","volume":"147","author":"C Laurencin","year":"2024","unstructured":"Laurencin C, Lancelot S, Brosse S, M\u00e9rida I, Redout\u00e9 J, Greusard E, et al. Noradrenergic alterations in Parkinson\u2019s disease: a combined 11C-yohimbine PET\/neuromelanin MRI study. Brain. 2024;147:1377\u201388. https:\/\/doi.org\/10.1093\/BRAIN\/AWAD338.","journal-title":"Brain"},{"key":"1499_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM14020209","author":"AF Kemp","year":"2024","unstructured":"Kemp AF, Kinnerup M, Johnsen B, Jakobsen S, Nahimi A, Gjedde A. EEG frequency correlates with \u03b12-Receptor density in Parkinson\u2019s Disease. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/BIOM14020209.","journal-title":"Biomolecules"},{"key":"1499_CR89","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.neuroimage.2011.03.012","volume":"56","author":"N Pavese","year":"2011","unstructured":"Pavese N, Rivero-Bosch M, Lewis SJ, Whone AL, Brooks DJ. Progression of monoaminergic dysfunction in Parkinson\u2019s Disease: a longitudinal 18F-dopa PET study. Neuroimage. 2011;56:1463\u20138. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.03.012.","journal-title":"Neuroimage"},{"key":"1499_CR90","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","volume":"29","author":"RY Moore","year":"2008","unstructured":"Moore RY, Whone AL, Brooks DJ. Extrastriatal monoamine neuron function in Parkinson\u2019s disease: an 18F-dopa PET study. Neurobiol Dis. 2008;29:381\u201390. https:\/\/doi.org\/10.1016\/j.nbd.2007.09.004.","journal-title":"Neurobiol Dis"},{"key":"1499_CR91","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-5-200009050-00009","author":"DS Goldstein","year":"2000","unstructured":"Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO. Cardiac sympathetic denervation in Parkinson Disease. Ann Intern Med. 2000. https:\/\/doi.org\/10.7326\/0003-4819-133-5-200009050-00009.","journal-title":"Ann Intern Med"},{"key":"1499_CR92","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","volume":"510","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Blumbergs PC, Cotton RGH, Blessing WW, Geffen LB. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson\u2019s disease. Brain Res. 1990;510:104\u20137. https:\/\/doi.org\/10.1016\/0006-8993(90)90733-R.","journal-title":"Brain Res"},{"key":"1499_CR93","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000012444","volume":"97","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn J, Prasuhn M, Fellbrich A, Strautz R, Lemmer F, Dreischmeier S, et al. Association of Locus Coeruleus and Substantia Nigra pathology with cognitive and motor functions in patients with Parkinson Disease. Neurology. 2021;97:e1007-16. https:\/\/doi.org\/10.1212\/WNL.0000000000012444.","journal-title":"Neurology"},{"key":"1499_CR94","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1093\/BRAIN\/AWAB142","volume":"144","author":"C O\u2019Callaghan","year":"2021","unstructured":"O\u2019Callaghan C, Hezemans FH, Ye R, Rua C, Jones PS, Murley AG, et al. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson\u2019s disease. Brain. 2021;144:2513\u201326. https:\/\/doi.org\/10.1093\/BRAIN\/AWAB142.","journal-title":"Brain"},{"key":"1499_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/J.NICL.2021.102873","author":"C Zhou","year":"2021","unstructured":"Zhou C, Guo T, Bai X, Wu JJ, Gao T, Guan X, et al. Locus coeruleus degeneration is associated with disorganized functional topology in Parkinson\u2019s disease. Neuroimage Clin. 2021. https:\/\/doi.org\/10.1016\/J.NICL.2021.102873.","journal-title":"Neuroimage Clin"},{"key":"1499_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/J.PARKRELDIS.2024.106558","author":"X Wang","year":"2024","unstructured":"Wang X, Huang P, Haacke EM, Wu P, Zhang X, Zhang H, et al. MRI index of glymphatic system mediates the influence of locus coeruleus on cognition in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2024. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2024.106558.","journal-title":"Parkinsonism Relat Disord"},{"key":"1499_CR97","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/BRAIN\/AWAE295","volume":"148","author":"AI Wiesman","year":"2025","unstructured":"Wiesman AI, Madge V, Fon EA, Dagher A, Collins DL, Baillet S. Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson\u2019s disease. Brain. 2025;148:875\u201385. https:\/\/doi.org\/10.1093\/BRAIN\/AWAE295.","journal-title":"Brain"},{"key":"1499_CR98","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/MDS.27682","volume":"34","author":"Y Li","year":"2019","unstructured":"Li Y, Wang C, Wang J, Zhou Y, Ye F, Zhang Y, et al. Mild cognitive impairment in de novo Parkinson\u2019s disease: a neuromelanin MRI study in Locus Coeruleus. Mov Disord. 2019;34:884\u201392. https:\/\/doi.org\/10.1002\/MDS.27682.","journal-title":"Mov Disord"},{"key":"1499_CR99","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1523\/JNEUROSCI.0289-22.2023","volume":"43","author":"R Ye","year":"2023","unstructured":"Ye R, Hezemans FH, O\u2019Callaghan C, Tsvetanov KA, Rua C, Jones PS, et al. Locus Coeruleus integrity is linked to response inhibition deficits in Parkinson\u2019s Disease and Progressive Supranuclear Palsy. J Neurosci. 2023;43:7028\u201340. https:\/\/doi.org\/10.1523\/JNEUROSCI.0289-22.2023.","journal-title":"J Neurosci"},{"key":"1499_CR100","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain. 2005;128:1314\u201322. https:\/\/doi.org\/10.1093\/brain\/awh445.","journal-title":"Brain"},{"issue":"2","key":"1499_CR101","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/S00702-023-02721-7","volume":"131","author":"G Palermo","year":"2024","unstructured":"Palermo G, Galgani A, Bellini G, Lombardo F, Martini N, Morganti R, et al. Neurogenic orthostatic hypotension in Parkinson\u2019s disease: is there a role for Locus Coeruleus magnetic resonance imaging? J Neural Transm. 2024;131(2):157\u201364. https:\/\/doi.org\/10.1007\/S00702-023-02721-7.","journal-title":"J Neural Transm"},{"key":"1499_CR102","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/BRAIN\/AWW006","volume":"139","author":"M Ehrminger","year":"2016","unstructured":"Ehrminger M, Latimier A, Pyatigorskaya N, Garcia-Lorenzo D, Leu-Semenescu S, Vidailhet M, et al. The Coeruleus\/Subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2016;139:1180\u20138. https:\/\/doi.org\/10.1093\/BRAIN\/AWW006.","journal-title":"Brain"},{"key":"1499_CR103","doi-asserted-by":"publisher","unstructured":"Dauvilliers Y, Schenck CH, Postuma RB, Iranzo A, Luppi PH, Plazzi G, et al. REM sleep behaviour disorder. Nat Rev Dis Primers [Internet]. Nat Rev Dis Primers; 2018 [cited 2025 Nov 26];4. https:\/\/doi.org\/10.1038\/S41572-018-0016-5","DOI":"10.1038\/S41572-018-0016-5"},{"key":"1499_CR104","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0140-673(65)92279-8","volume":"286","author":"DAL Owen","year":"1965","unstructured":"Owen DAL, Marsden CD. Effect of adrenergic \u03b2-blockade on Parkinsonian tremor. Lancet. 1965;286:1259\u201362. https:\/\/doi.org\/10.1016\/S0140-673(65)92279-8.","journal-title":"Lancet"},{"key":"1499_CR105","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/brain\/awx376","volume":"141","author":"J Pasquini","year":"2018","unstructured":"Pasquini J, Ceravolo R, Qamhawi Z, Lee JY, Deuschl G, Brooks DJ, et al. Progression of tremor in early stages of Parkinson\u2019s disease: A clinical and neuroimaging study. Brain [Internet]. 2018;141:811\u201321. https:\/\/doi.org\/10.1093\/brain\/awx376.","journal-title":"Brain [Internet]"},{"key":"1499_CR106","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","volume":"138","author":"Z Qamhawi","year":"2015","unstructured":"Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, et al. Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease. Brain. 2015;138:2964\u201373. https:\/\/doi.org\/10.1093\/brain\/awv215.","journal-title":"Brain"},{"key":"1499_CR107","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/brain\/awaa083","volume":"143","author":"MF Dirkx","year":"2020","unstructured":"Dirkx MF, Zach H, van Nuland AJ, Bloem BR, Toni I, Helmich RC. Cognitive load amplifies Parkinson\u2019s tremor through excitatory network influences onto the thalamus. Brain. 2020;143:1498\u2013511. https:\/\/doi.org\/10.1093\/brain\/awaa083.","journal-title":"Brain"},{"key":"1499_CR108","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ANA.27159","volume":"97","author":"A van der Heide","year":"2025","unstructured":"van der Heide A, Wessel M, Papadopetraki D, Geurts DEM, van Prooije TH, Gommans F, et al. Propranolol reduces Parkinson\u2019s tremor and inhibits tremor-related activity in the motor cortex: a placebo-controlled crossover trial. Ann Neurol. 2025;97:741\u201352. https:\/\/doi.org\/10.1002\/ANA.27159.","journal-title":"Ann Neurol"},{"key":"1499_CR109","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/mds.29506","volume":"38","author":"MF Dirkx","year":"2023","unstructured":"Dirkx MF, Shine JM, Helmich RC. Integrative brain states facilitate the expression of Parkinson\u2019s tremor. Mov Disord. 2023;38:1615\u201324. https:\/\/doi.org\/10.1002\/mds.29506.","journal-title":"Mov Disord"},{"key":"1499_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/J.NBD.2025.106960","author":"J Sun","year":"2025","unstructured":"Sun J, Chen L, Li L, Wu T, Feng T. Less locus coeruleus degeneration and its enhanced influence on neural circuit in Parkinson\u2019s tremor. Neurobiol Dis. 2025. https:\/\/doi.org\/10.1016\/J.NBD.2025.106960.","journal-title":"Neurobiol Dis"},{"key":"1499_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2023.1060935","author":"S Wang","year":"2023","unstructured":"Wang S, Wu T, Cai Y, Yu Y, Chen X, Wang L. Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson\u2019s disease with freezing of gait. Front Aging Neurosci. 2023. https:\/\/doi.org\/10.3389\/FNAGI.2023.1060935.","journal-title":"Front Aging Neurosci"},{"key":"1499_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/J.NBD.2023.106048","author":"JL McKay","year":"2023","unstructured":"McKay JL, Nye J, Goldstein FC, Sommerfeld B, Smith Y, Weinshenker D, et al. Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson\u2019s disease. Neurobiol Dis. 2023. https:\/\/doi.org\/10.1016\/J.NBD.2023.106048.","journal-title":"Neurobiol Dis"},{"key":"1499_CR113","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/BRAIN\/AWZ314","volume":"143","author":"D Weiss","year":"2020","unstructured":"Weiss D, Schoellmann A, Fox MD, Bohnen NI, Factor SA, Nieuwboer A, et al. Freezing of gait: understanding the complexity of an enigmatic phenomenon. Brain. 2020;143:14\u201330. https:\/\/doi.org\/10.1093\/BRAIN\/AWZ314.","journal-title":"Brain"},{"key":"1499_CR114","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/MDS.28999","volume":"37","author":"NL Taylor","year":"2022","unstructured":"Taylor NL, Wainstein G, Quek D, Lewis SJG, Shine JM, Ehgoetz Martens KA. The contribution of noradrenergic activity to anxiety-induced freezing of gait. Mov Disord. 2022;37:1432\u201343. https:\/\/doi.org\/10.1002\/MDS.28999.","journal-title":"Mov Disord"},{"key":"1499_CR115","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1162\/NETN_A_00042","volume":"2","author":"JM Shine","year":"2018","unstructured":"Shine JM, van den Brink RL, Hernaus D, Nieuwenhuis S, Poldrack RA. Catecholaminergic manipulation alters dynamic network topology across cognitive states. Netw Neurosci. 2018;2:381\u201396. https:\/\/doi.org\/10.1162\/NETN_A_00042.","journal-title":"Netw Neurosci"},{"issue":"7","key":"1499_CR116","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/J.TICS.2019.04.002","volume":"23","author":"JM Shine","year":"2019","unstructured":"Shine JM. Neuromodulatory influences on integration and segregation in the brain. Trends Cogn Sci. 2019;23(7):572\u201383. https:\/\/doi.org\/10.1016\/J.TICS.2019.04.002.","journal-title":"Trends Cogn Sci"},{"key":"1499_CR117","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/157015908785777229","volume":"6","author":"ER Samuels","year":"2008","unstructured":"Samuels ER, Szabadi E. Functional neuroanatomy of the noradrenergic Locus Coeruleus: Its roles in the regulation of arousal and autonomic function Part I: Principles of functional organisation. Curr Neuropharmacol. 2008;6:235\u201353. https:\/\/doi.org\/10.2174\/157015908785777229.","journal-title":"Curr Neuropharmacol"},{"key":"1499_CR118","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neuroimage.2017.02.025","volume":"150","author":"M Mather","year":"2017","unstructured":"Mather M, Joo Yoo H, Clewett DV, Lee TH, Greening SG, Ponzio A, et al. Higher Locus Coeruleus MRI contrast is associated with lower parasympathetic influence over heart rate variability. Neuroimage. 2017;150:329\u201335. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.02.025.","journal-title":"Neuroimage"},{"key":"1499_CR119","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/MDS.22775","volume":"24","author":"Y Miki","year":"2009","unstructured":"Miki Y, Mori F, Wakabayashi K, Kuroda N, Orimo S. Incidental Lewy body disease restricted to the heart and stellate ganglia. Mov Disord. 2009;24:2299\u2013301. https:\/\/doi.org\/10.1002\/MDS.22775.","journal-title":"Mov Disord"},{"key":"1499_CR120","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1212\/WNL.52.6.1269","volume":"52","author":"K Iwanaga","year":"1999","unstructured":"Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, et al. Lewy body\u2013type degeneration in cardiac plexus in Parkinson\u2019s and incidental Lewy body diseases. Neurology. 1999;52:1269\u20131269. https:\/\/doi.org\/10.1212\/WNL.52.6.1269.","journal-title":"Neurology"},{"issue":"5","key":"1499_CR121","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41593-025-01910-9","volume":"28","author":"KB Andersen","year":"2025","unstructured":"Andersen KB, Krishnamurthy A, Just MK, Van Den Berge N, Skj\u00e6rb\u00e6k C, Horsager J, et al. Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals. Nat Neurosci. 2025;28(5):925\u201336. https:\/\/doi.org\/10.1038\/s41593-025-01910-9.","journal-title":"Nat Neurosci"},{"issue":"5","key":"1499_CR122","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/MDS.25431","volume":"28","author":"JA Palma","year":"2013","unstructured":"Palma JA, Carmona-Abellan MM, Barriobero N, Trevino-Peinado C, Garcia-Lopez M, Fernandez-Jarne E, et al. Is cardiac function impaired in premotor Parkinson\u2019s disease? A retrospective cohort study. Mov Disord. 2013;28(5):591\u20136. https:\/\/doi.org\/10.1002\/MDS.25431.","journal-title":"Mov Disord"},{"key":"1499_CR123","doi-asserted-by":"publisher","unstructured":"Goldstein DS, Sharabi Y, Karp BI, Bentho O, Saleem A, Pacak K, et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clinical Autonomic Research [Internet]. Springer; 2007 [cited 2025 Dec 10];17:118\u201321. https:\/\/doi.org\/10.1007\/S10286-007-0396-1\/FIGURES\/3","DOI":"10.1007\/S10286-007-0396-1\/FIGURES\/3"},{"key":"1499_CR124","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first Parkinson\u2019s disease: A multimodal imaging case-control study. Brain. 2020;143:3077\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa238.","journal-title":"Brain"},{"key":"1499_CR125","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","volume":"17","author":"K Knudsen","year":"2018","unstructured":"Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Otto M, Svendsen KB, et al. In-vivo staging of pathology in REM sleep behaviour disorder: A multimodality imaging case-control study. Lancet Neurol. 2018;17:618\u201328. https:\/\/doi.org\/10.1016\/S1474-4422(18)30162-5.","journal-title":"Lancet Neurol"},{"key":"1499_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/J.NBD.2019.104700","volume":"134","author":"Z Chen","year":"2020","unstructured":"Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson\u2019s disease: implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis. 2020;134:104700. https:\/\/doi.org\/10.1016\/J.NBD.2019.104700.","journal-title":"Neurobiol Dis"},{"key":"1499_CR127","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83:328\u201335. https:\/\/doi.org\/10.1212\/WNL.0000000000000615.","journal-title":"Neurology"},{"key":"1499_CR128","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1212\/WNL.0B013E3182516244","volume":"78","author":"I Richard","year":"2012","unstructured":"Richard I, McDermott M, Kurlan R, Lyness J, Como P, Pearson N, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 2012;78:1229. https:\/\/doi.org\/10.1212\/WNL.0B013E3182516244.","journal-title":"Neurology"},{"key":"1499_CR129","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1517\/14656566.2012.736490","volume":"13","author":"U Bonuccelli","year":"2012","unstructured":"Bonuccelli U, Meco G, Fabbrini G, Tessitore A, Pierantozzi M, Stocchi F, et al. A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson\u2019s disease. Expert Opin Pharmacother. 2012;13:2269\u201380. https:\/\/doi.org\/10.1517\/14656566.2012.736490.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"1499_CR130","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/MDS.22307","volume":"24","author":"L Marsh","year":"2009","unstructured":"Marsh L, Biglan K, Gerstenhaber M, Williams JR. Atomoxetine for the treatment of executive dysfunction in Parkinson\u2019s disease: a pilot open-label study. Mov Disord. 2009;24(2):277. https:\/\/doi.org\/10.1002\/MDS.22307.","journal-title":"Mov Disord"},{"key":"1499_CR131","doi-asserted-by":"publisher","unstructured":"Weintraub D, Mavandadi S, Mamikonyan E, Siderowf AD, Duda JE, Hurtig HI, et al. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease[image]. Neurology [Internet]. Lippincott Williams and Wilkins; 2010 [cited 2025 Dec 19];75:448. https:\/\/doi.org\/10.1212\/WNL.0B013E3181EBDD79","DOI":"10.1212\/WNL.0B013E3181EBDD79"},{"key":"1499_CR132","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1212\/WNL.0B013E3182143537","volume":"76","author":"AJ Espay","year":"2011","unstructured":"Espay AJ, Dwivedi AK, Payne M, Gaines L, Vaughan JE, Maddux BN, et al. Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial. Neurology. 2011;76:1256\u201362. https:\/\/doi.org\/10.1212\/WNL.0B013E3182143537.","journal-title":"Neurology"},{"key":"1499_CR133","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(12)70106-0","volume":"11","author":"C Moreau","year":"2012","unstructured":"Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson\u2019s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol. 2012;11:589\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(12)70106-0.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1499_CR134","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/J.1440-1819.2003.01207.X","volume":"58","author":"S Miyazaki","year":"2004","unstructured":"Miyazaki S, Uchida S, Mukai J, Nishihara K. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion. Psychiatry Clin Neurosci. 2004;58(2):138\u201344. https:\/\/doi.org\/10.1111\/J.1440-1819.2003.01207.X.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"1499_CR135","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0893-133X(99)00060-3","volume":"21","author":"JS Franowicz","year":"1999","unstructured":"Franowicz JS, Arnsten AFT. Treatment with the noradrenergic alpha-2 agonist clonidine, but not diazepam, improves spatial working memory in normal young Rhesus monkeys. Neuropsychopharmacology. 1999;21(5):611\u201321. https:\/\/doi.org\/10.1016\/S0893-133X(99)00060-3.","journal-title":"Neuropsychopharmacology"},{"key":"1499_CR136","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WNF.0B013E3182741C39","volume":"35","author":"AE Cavanna","year":"2012","unstructured":"Cavanna AE, Selvini C, Termine C, Balottin U, Eddy CM. Tolerability profile of clonidine in the treatment of adults with Tourette syndrome. Clin Neuropharmacol. 2012;35:269\u201372. https:\/\/doi.org\/10.1097\/WNF.0B013E3182741C39.","journal-title":"Clin Neuropharmacol"},{"key":"1499_CR137","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/J.JAAC.2013.11.009","volume":"53","author":"T Hirota","year":"2014","unstructured":"Hirota T, Schwartz S, Correll CU. Alpha-2 agonists for Attention-Deficit\/Hyperactivity Disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. J Am Acad Child Adolesc Psychiatry. 2014;53:153\u201373. https:\/\/doi.org\/10.1016\/J.JAAC.2013.11.009.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1499_CR138","doi-asserted-by":"publisher","unstructured":"Laurencin C, Timestit N, Marques A, Duchez DD, Giordana C, Meoni S, et al. Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson\u2019s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial. J Neurol [Internet]. Springer Science and Business Media Deutschland GmbH; 2023 [cited 2025 Dec 19];270:4851\u20139. https:\/\/doi.org\/10.1007\/S00415-023-11814-Y\/TABLES\/3","DOI":"10.1007\/S00415-023-11814-Y\/TABLES\/3"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01499-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01499-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01499-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:52:36Z","timestamp":1781592756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-026-01499-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1499"],"URL":"https:\/\/doi.org\/10.1007\/s11910-026-01499-x","relation":{},"ISSN":["1534-6293"],"issn-type":[{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Jacopo Pasquini, Giovanni Palermo, Nicola Pavese and Roberto Ceravolo declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}}],"article-number":"30"}}